Agios Pharmaceuticals, Inc. (AGIO)
27.31
-0.13
(-0.47%)
USD |
NASDAQ |
Jun 09, 14:05
Agios Pharmaceuticals SG&A Expense (Quarterly) : 48.30M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 607.30M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Incyte Corp. | 328.09M |
| AbbVie, Inc. | 3.578B |
| Indivior Pharmaceuticals, Inc. | 124.00M |